Clinical Trials Browser

Withdrawn × Observational × Prostatic Neoplasms × Clear all

NCT04243473 2026-03-03

Biopsy Collection for Men Undergoing Brachytherapy for Prostate Cancer

Prostatic Neoplasms

NCT02869282 2025-09-17

CHEMOPROST

Prostatic Neoplasms

NCT06457854 2025-03-12

PROCeed-BR

Prostatic Neoplasms

NCT02608359 2025-02-03

A Post-marketing Surveillance to Assess Safety of Abiraterone Acetate (Zytiga) in Indian Participants With Metastatic, Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT02905201 2025-02-03

TOGETHER

Prostatic Neoplasms

NCT04495959 2025-01-08

Dynamic Whole Body PET/ MRI

Prostatic Neoplasms

NCT01350180 2024-12-10

Assessing DNA Changes in High Risk Prostate Cancer to Determine Prognosis

Prostatic Neoplasms

NCT02588404 2024-12-10

The Predictive Value of TMPRSS2-ERG Fusion in High Risk Prostate Cancer Patient

Prostatic Neoplasms

NCT04985357 2024-11-25

Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to Drugs

BreastEndocrineGastrointestinalGenitourinaryGynecologicHead & NeckOther solid neoplasmThoracic

Anus Neoplasms, Appendiceal Neoplasms, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Carcinoma, Hepatocellular, Laryngeal Neoplasms, Lip Neoplasms, Lung Neoplasms, Mesothelioma, Mouth Neoplasms, Neoplasms, Unknown Primary, Oropharyngeal Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Paranasal Sinus Neoplasms, Penile Neoplasms, Prostatic Neoplasms, Thymoma, Vulvar Neoplasms, Pleural Effusion, Malignant, Carcinoma, Neuroendocrine, Cholangiocarcinoma, Carcinoma, Ductal, Small Cell Lung Carcinoma

NCT03990194 2024-10-31

LEPTO

Prostatic Neoplasms

NCT03970863 2024-02-09

Focal Therapy for Localized Prostate Cancer

Prostatic Neoplasms

NCT00323180 2024-01-11

Investigation of Protein Biomarkers of Prostate Cancer

Prostatic Neoplasms

NCT00323388 2024-01-11

Identification of Risk Allels for Prostate Cancer

Prostatic Neoplasms

NCT03494803 2023-12-22

Detection of Prostate Cancer With Non-invasive Method Based on DNA Methylation of Circulated Tumor DNA, PBMC

Prostatic Neoplasms

NCT06159998 2023-12-07

New Markers for Treatment Response to Radiotherapy in Prostate Cancer

Prostatic Neoplasms

NCT01792882 2023-02-28

GBCPRT0008

BreastGastrointestinalGenitourinaryOther hematologic neoplasmThoracic

Breast Neoplasms, Lung Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT00581503 2022-10-20

Early Detection and Staging of Endobronchial Lung and Pleural Cancer, Airway Injury, and Prostate Cancer

GenitourinaryThoracic

Lung Neoplasms, Prostatic Neoplasms

NCT04339920 2022-01-04

Spermine Measuring Device Evaluation Protocol

Prostatic Neoplasms

NCT03495479 2021-10-18

CAMPAS

Prostatic Neoplasms

NCT00161252 2021-09-27

Assessment of Primary Androgen Deprivation Therapy for Non-metastatic Prostate Cancer Among Elderly

Prostatic Neoplasms

NCT03563352 2020-12-14

Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

BreastGastrointestinalGenitourinary

Breast Neoplasms, Gastrointestinal Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

NCT02822963 2020-10-06

Impact of Anticoagulants and Antiplatelets in Patients on Transurethral Resection of the Prostate

Prostatic Hyperplasia, Prostatic Neoplasms

NCT01766869 2020-03-18

GCC 1261

Prostatic Neoplasms

NCT00980993 2019-11-04

Quantification of Respiratory-induced Prostate Motion

Prostatic Neoplasms, Respiratory Aspiration

NCT01275651 2019-01-24

Biomarkers in Bone Marrow and Blood Samples From Patients With Prostate Cancer Treated With Ketoconazole

Prostatic Neoplasms

NCT03296124 2018-11-16

PRX32

Prostatic Neoplasms

NCT03325127 2018-10-31

Outcomes of mCRPC Patients Treated With Ra-223 Concomitant With Abiraterone or Enzalutamide- A Chart Review Study

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant

NCT00562341 2018-08-23

Effect of Lap-Band Induced Weight Loss on Serum PSA Levels

GenitourinaryHead & NeckOther

Salivary Gland Adenoma, Pleomorphic, Obesity, Prostatic Neoplasms

NCT00922818 2018-08-20

RPP

Neoplasms, Prostatic Neoplasms, Recurrence

NCT01260909 2017-12-02

Real-Time MV/kV Image Guided Radiation Therapy

Prostatic Neoplasms

NCT00767845 2016-11-09

Symptom Management in African-American Men With Localized Prostate Cancer

Prostatic Neoplasms

NCT01379378 2016-07-22

Male Stress Urinary Incontinence and Sexual Health

Prostatic Neoplasms

NCT01173146 2016-05-25

Imaging of Residual Tumor During Prostatectomy

Prostatic Neoplasms

NCT00801996 2016-05-13

ProstateCA

Prostatic Neoplasms

NCT02110849 2016-04-07

Prostate Cancer Parameters for Patients Receiving Proton Treatment

Neoplasms, Prostatic Neoplasms

NCT01692483 2015-12-02

Post-marketing Surveillance Study on the Safety and Effectiveness of Abiraterone Acetate Among Adult Filipino Male Patients With Advanced Metastatic Castration Resistant Prostate Cancer

Prostatic Neoplasms

NCT01279785 2015-11-25

A Pilot Study of 123I-MIP-1072 SPECT/CT Imaging With Optional Compact Gamma Camera Probe Imaging in Men With Prostate Cancer Undergoing Prostatectomy

Adenocarcinoma, Prostatic Neoplasms

NCT01274572 2015-04-07

Blood for Immune Response to Provenge® in HRPC

Prostatic Neoplasms

NCT01838265 2014-12-08

MGM

Prostatic Neoplasms

NCT01617174 2013-11-08

Observational Longitudinal Study of Pain in Men With Metastatic Castrate-Resistant Prostate Cancer

Prostatic Neoplasms

NCT01899391 2013-07-15

Periperal Blood Lymphocytes During Prostate RT

Prostatic Neoplasms

NCT00877617 2012-07-30

Quality of Life in Men With High Risk Localized Prostate Cancer

Prostatic Neoplasms